Below are the financial statements of Chugai Pharmaceutical, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of JPY | 2024 | 2023 |
|---|---|---|
| Revenue | 1,170,611a | 1,111,367a |
| Sales | 997,901a | 974,493a |
| Other revenue | 172,710a | 136,874a |
| Cost of sales | -339,409a | -413,306a |
| Gross profit | 831,201a | 698,061a |
| Research and development | -181,440a | -174,868a |
| Selling, general and administration | -110,098a | -112,580a |
| Other operating income (expense) | 2,339a | 28,561a |
| Operating profit | 542,002a | 439,174a |
| Financing costs | -5a | -27a |
| Other financial income (expense) | 1,027a | 4,674a |
| Profit before taxes | 543,034a | 443,821a |
| Income taxes | -155,717a | -118,349a |
| Net income | 387,317a | 325,472a |
| Chugai shareholders | 387,317a | 325,472a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Chugai Pharmaceutical’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.